title: mTHPC-mediated photodynamic treatment of Lewis lung carcinoma in vitro and in vivo.
abstract: OBJECTIVE
  The ongoing search for the enhancement of efficacy of photodynamic therapy stimulates the interest in molecular mechanisms of the response to the treatment. Looking for the cell line suitable for investigation of cellular response both in vivo and in vitro, we evaluated phototoxicity of m-tetrakis-(3-hydroxyphenyl)-chlorin (mTHPC) on viability of Lewis lung carcinoma (LLC1) cells in vitro, growth of murine transplantable tumor, and mice survival.
  
  
  METHODS
  LLC1 cell culture and male C57BL/6 mice bearing Lewis lung carcinoma were used for the experiments. Photodynamic treatment was mediated by m-tetrakis-(3-hydroxyphenyl)-chlorin as a photosensitizer. Light emitting diode array was used for illumination. The effect of the photodynamic treatment was evaluated by comparison of viability of control and treated cells, growth of tumors, and survival of the control and treated mice.
  
  
  RESULTS
  In vitro, a cytotoxic dose inducing a reduction in viability of LLC1 cells by 50% was achieved at 60 mJ/cm(2) and approximately 400 ng/mL of the photosensitizer, or 30 mJ/cm(2) and 600 ng/mL of mTHPC. Both the concentration of the photosensitizer and duration of light exposure were significant determinants of cytotoxic effect. In vivo, an injection of 0.25 mg/kg of mTHPC to mice bearing Lewis lung tumor and illumination at 120 J/cm(2) taking place after 24 h significantly inhibited tumor growth and prolonged mice survival. However, the tumors regained their growth potential after 9 days.
  
  
  CONCLUSIONS
  Photodynamic treatment mediated by m-tetrakis-(3-hydroxyphenyl)-chlorin had a significant effect on LLC1 cells in vitro and growth of Lewis lung carcinoma in vivo.
authors.affiliation: Department of Biochemistry and Biophysics, Vilnius University, M. K. Ciurlionio 21/27, 03101 Vilnius, Lithuania.
authors.forename: Daiva
authors.initials: D
authors.lastname: Dabkeviciene
authors.forename: Vaidotas
authors.initials: V
authors.lastname: Stankevicius
authors.forename: Grazina
authors.initials: G
authors.lastname: Grazeliene
authors.forename: Arvydas
authors.initials: A
authors.lastname: Markuckas
authors.forename: Janina
authors.initials: J
authors.lastname: Didziapetriene
authors.forename: Vida
authors.initials: V
authors.lastname: Kirveliene
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D018827:Carcinoma, Lewis Lung / Q000188:drug therapy* / Q000401:mortality; D045744:Cell Line, Tumor; D002470:Cell Survival; D017408:Guidelines as Topic; D053208:Kaplan-Meier Estimate; D008297:Male; D008652:Mesoporphyrins / Q000008:administration & dosage*; D051379:Mice; D008962:Models, Theoretical; D009368:Neoplasm Transplantation; D010778:Photochemotherapy / Q000379:methods; D017319:Photosensitizing Agents / Q000008:administration & dosage*; D013997:Time Factors
chemical_list: D008652:Mesoporphyrins; D017319:Photosensitizing Agents; C072269:temoporfin